CURX vs TSN · $8.9M cap vs P/E 22, rev $54.44B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus Tyson Foods Inc (TSN) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Tyson Foods Inc (TSN) is a farm products company listed on US.
CURX does not have a complete income-statement cache yet.
Latest reported TSN revenue for 2025-09-27 was $54.44B. Net income was $507.0M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
CURX currently screens at market cap $8.9M. TSN currently screens at market cap $20.43B and trailing P/E 22.3.
Not investment advice. Open the CURX and TSN stock pages for the full models.
Not investment advice.